This is a testament to the untapped potential of AI in scientific research, providing a new paradigm for approaching and solving intricate problems.
The FDA recently approved a pioneering CRISPRโCas9 therapy for sickle cell disease, marking a historic moment in genetic treatment. But that it is just the tip of the iceberg.
While one patient is being operated on, the next one is prepared and is immediately rolled in as soon as the first one is finished.
The approvals include the first-ever CRISPR-Cas9 based drug, Casgevy, and a gene therapy drug, Lyfgenia, marking a milestone in medical biotechnology.
With expansion to new countries, including Kenya, the Philippines, and Zambia, it has a presence in over 50 countries.
GraphCast predicts weather up to 10 days in advance with remarkable accuracy, and uses only seconds to process the data, surpassing traditional methods.
Obesity, a major health problem affecting about 70% of adults in the U.S. and over half in Europe, is linked to several serious diseases. Recently, a new class of drugs, GLP-1 receptor agonists, originally for diabetes, has shown significant promise in treating obesity with manageable side effects.
Cling Systems is a Swedish startup helping companies recycle used electric car batteries. Now they've secured 1.3 million USD in funding.
Commercial operations have started at a new generation nuclear reactor that is the first of its kind in the world.